Daily Stock Analysis: Gilead Sciences, Inc. By: TalkMarkets July 18, 2022 at 05:00 AM EDT Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Read More >> Related Stocks: Gilead Sciences
